The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

Bedtime dosing with antihypertensive medication yields better nocturnal blood pressure control and improved circadian rhythm.

The amended dosing regimen was approved based on results from a post hoc analysis of the phase 2 MagnetisMM-3 trial.

You can lower your heart rate with lifestyle changes like regular exercise and stress management. Learn more tips and when to ...

Background Restarting direct oral anticoagulants (DOACs) after a serious bleeding event in patients with atrial fibrillation ...